Literature DB >> 4018499

Control of gastric pH with cimetidine: boluses versus primed infusions.

M J Ostro, J A Russell, S J Soldin, W A Mahon, K N Jeejeebhoy.   

Abstract

Previous studies suggest that antacids are more effective than intravenous cimetidine in maintaining the gastric pH above 4.0 in acutely ill patients. We hypothesized that this was because blood levels of cimetidine are not sustained at therapeutic levels with the bolus doses. The purpose of this study was to compare gastric pH and serum cimetidine levels when cimetidine was administered as bolus versus infusion. We studied 23 acutely ill patients who received intravenous cimetidine given as boluses and primed infusions. The gastric pH could be maintained above 4.0 with infusions of up to 50 mg/h (1200 mg/day) in 20 patients, compared with only 5 patients with bolus administrations of up to 300 mg every 6 h (1200 mg/day). The differences in ability to maintain the gastric pH above 4.0 were entirely due to the reduced ability of bolus infusion to maintain an adequate serum level. Neither technique could maintain the pH above 4.0 in 3 patients, all of whom had received cimetidine recently. A gastric pH greater than 4.0 correlated directly with a therapeutic serum cimetidine level. We conclude that infusions of cimetidine are better able to sustain therapeutic blood levels and, therefore, are superior to bolus cimetidine in maintaining gastric pH above 4.0. Some patients, however, may not respond to cimetidine even if therapeutic levels are achieved and may require supplemental antacids.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4018499     DOI: 10.1016/0016-5085(85)90447-0

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  18 in total

1.  Food but not a chemically defined diet interferes with maintenance of intragastric pH at a predefined level using continuous pH-stat-adjusted intravenous infusion of ranitidine in healthy volunteers.

Authors:  A B Thomson; P Kirdeikis; R Lastiwka; L Zuk; M Jen; M Elias; P Johnston
Journal:  Dig Dis Sci       Date:  1999-09       Impact factor: 3.199

2.  Twenty-four-hour intragastric pH patterns in ICU patients on ranitidine.

Authors:  J G Moore; T P Clemmer; S Taylor; A L Bishop; S Maggio
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

3.  A clinical guide to using intravenous proton-pump inhibitors in reflux and peptic ulcers.

Authors:  Sandy H Pang; David Y Graham
Journal:  Therap Adv Gastroenterol       Date:  2010-01       Impact factor: 4.409

4.  Modulation of gastric pH by continuous gastric and jejunal infusion of cimetidine.

Authors:  U K Murthy; W G Linscheer
Journal:  Dig Dis Sci       Date:  1991-02       Impact factor: 3.199

Review 5.  Histamine H2-receptor antagonists in peptic ulcer disease. Evidence for a prophylactic use.

Authors:  J Nash; L Lambert; M Deakin
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

6.  Control of gastric pH with ranitidine in patients with Crohn's disease receiving total parenteral nutrition. Comparison of two intravenous regimens.

Authors:  T Matsui; A Motomura; M Arita; Y Takeyama; T Sakurai; T Yao
Journal:  J Gastroenterol       Date:  1996-02       Impact factor: 7.527

7.  Effect of intravenous omeprazole on intragastric pH during intravenous infusion of amino acids.

Authors:  L C Baak; J B Jansen; C B Lamers
Journal:  Dig Dis Sci       Date:  1990-05       Impact factor: 3.199

8.  Stress-related Mucosal Disease.

Authors:  Mitchell J. Spirt
Journal:  Curr Treat Options Gastroenterol       Date:  2003-04

9.  Parenteral control of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.

Authors:  R Vinayek; W F Hahne; A R Euler; J A Norton; R T Jensen
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

10.  Optimal therapy for stress gastritis.

Authors:  R V Maier; D Mitchell; L Gentilello
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.